Your browser doesn't support javascript.
loading
Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer.
Owonikoko, Taofeek K; Zhang, Guojing; Deng, Xingming; Rossi, Michael R; Switchenko, Jeffrey M; Doho, Gregory H; Chen, Zhengjia; Kim, Sungjin; Strychor, Sandy; Christner, Susan M; Beumer, Jan; Li, Chunyang; Yue, Ping; Chen, Alice; Sica, Gabriel L; Ramalingam, Suresh S; Kowalski, Jeanne; Khuri, Fadlo R; Sun, Shi-Yong.
Affiliation
  • Owonikoko TK; Department of Hematology & Medical Oncology, Emory University School of Medicine, Atlanta, Georgia; Winship Cancer Institute of Emory University, Atlanta, Georgia.
Cancer Med ; 3(6): 1579-94, 2014 Dec.
Article in En | MEDLINE | ID: mdl-25124282
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzimidazoles / Antineoplastic Combined Chemotherapy Protocols / Small Cell Lung Carcinoma / Poly(ADP-ribose) Polymerase Inhibitors / Lung Neoplasms Type of study: Clinical_trials Limits: Animals / Humans Language: En Journal: Cancer Med Year: 2014 Document type: Article Affiliation country: Georgia Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzimidazoles / Antineoplastic Combined Chemotherapy Protocols / Small Cell Lung Carcinoma / Poly(ADP-ribose) Polymerase Inhibitors / Lung Neoplasms Type of study: Clinical_trials Limits: Animals / Humans Language: En Journal: Cancer Med Year: 2014 Document type: Article Affiliation country: Georgia Country of publication: United States